Rocket


Overview
Financials
News + Filings
Key Docs
Charts
Holdings
Ownership
Insiders





All
All (ex-4s)
10-K
10-Q
8-K
3,4,5
Proxy
Prospectus
Other


Tags
Quarterly results
Appointed director
CC transcript

VERTEX PHARMACEUTICALS INC / MA (VRTX) Create: Alert

All | News | Filings
Date FiledTypeDescription
10/11/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
10/10/2023 3 Form 3 - Initial statement of beneficial ownership of securities:
10/06/2023 144 Form 144 - Report of proposed sale of securities:
10/05/2023 4 Bozic Carmen (EVP and CMO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 5,651 shares @ $345.28, valued at $2M
10/05/2023 8-K Departure of Directors or Certain Officers; Election of Directors; Appointment of Certain Officers: Compensatory Arrangements...
10/03/2023 4 Biller Jonathan (EVP and Chief Legal Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Paid exercise price by delivering 408 shares @ $350.72, valued at $143.1k
Sold 610 shares @ $346.76, valued at $211.5k
10/03/2023 144 Form 144 - Report of proposed sale of securities:
10/02/2023 144 Form 144 - Report of proposed sale of securities:
08/25/2023 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 2,500 shares @ $355, valued at $887.5k
08/23/2023 144 Form 144 - Report of proposed sale of securities:
08/14/2023 4 Kearney Terrence C (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 10,000 shares @ $350, valued at $3.5M
Exercised 10,000 options to buy @ $127.54, valued at $1.3M
08/14/2023 4 Tatsis Ourania (EVP, Chief Reg. & Quality Off.) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 5,750 shares @ $345.79, valued at $2M
08/14/2023 4 Sachdev Amit (EVP, Chief Patient Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 10,031 shares @ $350, valued at $3.5M
08/11/2023 4 ALTSHULER DAVID (EVP, Global Research and CSO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 63 shares @ $345.51, valued at $21.8k
08/11/2023 4 Bhatia Sangeeta N. (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 242 shares @ $345.51, valued at $83.6k
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/10/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 144 Form 144 - Report of proposed sale of securities:
08/09/2023 144 Form 144 - Report of proposed sale of securities:
08/02/2023 10-Q Quarterly Report for the period ended June 30, 2023
08/01/2023 8-K Quarterly results
07/18/2023 4 SACHS BRUCE I (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 1,697 shares @ $355.54, valued at $603.4k
Sold 5,711 shares @ $356.75, valued at $2M
Sold 3,842 shares @ $357.29, valued at $1.4M
Granted 125 restricted stock units @ $350.79, valued at $43.8k
Exercised 11,250 options to buy @ $127.54, valued at $1.4M
07/18/2023 4 MCKENZIE DIANA (Director) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Granted 90 restricted stock units @ $350.79, valued at $31.5k
07/18/2023 4 Form 4 - Statement of changes in beneficial ownership of securities:
07/17/2023 144 Form 144 - Report of proposed sale of securities:
07/17/2023 144 Form 144 - Report of proposed sale of securities:
06/01/2023 4 Arbuckle Stuart A (EVP, COO) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 82 shares @ $329.82, valued at $27k
06/01/2023 4 Ambrose Kristen (SVP & Chief Accounting Officer) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 289 shares @ $329.82, valued at $95.3k
05/18/2023 8-K Submission of Matters to a Vote of Security Holders  Interactive Data
05/09/2023 4 Sanna Bastiano (EVP, Cell & Genetic Therapies) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 422 shares @ $350.03, valued at $147.7k
Sold 2,850 shares @ $350, valued at $997.5k
05/09/2023 4 LEIDEN JEFFREY M (Executive Chairman) has filed a Form 4 on VERTEX PHARMACEUTICALS INC / MA
Txns: Sold 708 shares @ $349.38, valued at $247.4k
Sold 171 shares @ $350.3, valued at $59.9k
Sold 1,125 shares @ $349, valued at $392.6k
05/08/2023 144 Form 144 - Report of proposed sale of securities:
  Next >>

Rocket Data Systems, Inc. © 2019 | Contact Us | Data Disclaimer | Terms of Use | Privacy